JNJ Jun 2024 165.000 call
| Previous Close | 17.30 |
| Open | 15.05 |
| Bid | 12.90 |
| Ask | 14.20 |
| Strike | 165.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 13.25 - 15.05 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.06k |
- Bloomberg
J&J Can’t Use Bankruptcy to End Cancer Suits Over Baby Powder, Court Says
(Bloomberg) -- Johnson & Johnson can’t use bankruptcy to resolve more than 40,000 cancer lawsuits over its baby powder, a federal appeals court ruled. Most Read from BloombergAdani Rout Hits $68 Billion as Fight With Hindenburg IntensifiesAdani Tries to Calm Investors With 413-Page Hindenburg RebuttalWall Street Is Losing Out to Amateur Buyers in the Housing SlumpHistoric Crash for Memory Chips Threatens to Wipe Out EarningsAdani Backed by UAE Royals Buying $400 Million in Share SaleThe three-ju
- Reuters
U.S. court rejects J&J bankruptcy strategy for tens of thousands of talc lawsuits
(Reuters) -A U.S. appeals court upended Johnson & Johnson's attempt to offload into bankruptcy tens of thousands of lawsuits over its talc products, ruling the healthcare conglomerate improperly placed a subsidiary into Chapter 11 proceedings even though it did not face financial distress. The decision by the U.S. 3rd Circuit Court of Appeals in Philadelphia on Monday dismissed a Chapter 11 petition filed by a recently created J&J subsidiary in October to address more than 38,000 lawsuits from plaintiffs alleging the company’s baby powder and other talc products caused cancer. Before the bankruptcy, J&J faced costs from $3.5 billion in verdicts and settlements, including one in which 22 women were eventually awarded a judgment of more than $2 billion, according to bankruptcy-court records.
- Reuters
UPDATE 4-U.S. court rejects J&J bankruptcy strategy for tens of thousands of talc lawsuits
A U.S. appeals court upended Johnson & Johnson's attempt to offload into bankruptcy tens of thousands of lawsuits over its talc products, ruling the healthcare conglomerate improperly placed a subsidiary into Chapter 11 proceedings even though it did not face financial distress. The decision by the U.S. 3rd Circuit Court of Appeals in Philadelphia on Monday dismissed a Chapter 11 petition filed by a recently created J&J subsidiary in October to address more than 38,000 lawsuits from plaintiffs alleging the company’s baby powder and other talc products caused cancer. Before the bankruptcy, J&J faced costs from $3.5 billion in verdicts and settlements, including one in which 22 women were eventually awarded a judgment of more than $2 billion, according to bankruptcy-court records.
